Weil Company, Inc. Singular Genomics Systems, Inc. Transaction History
Weil Company, Inc.
- $239 Million
- Q1 2024
A detailed history of Weil Company, Inc. transactions in Singular Genomics Systems, Inc. stock. As of the latest transaction made, Weil Company, Inc. holds 68,202 shares of OMIC stock, worth $573,578. This represents 0.01% of its overall portfolio holdings.
Number of Shares
68,202
Previous 138,202
50.65%
Holding current value
$573,578
Previous $63,000
46.03%
% of portfolio
0.01%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding OMIC
# of Institutions
45Shares Held
24.7MCall Options Held
13.2KPut Options Held
0-
Deerfield Management Company, L.P. (Series C) New York, NY4.98MShares$41.9 Million0.05% of portfolio
-
Arch Venture Management, LLC Chicago, IL3.8MShares$31.9 Million2.82% of portfolio
-
Qvidtvm Management LLC New York, NY2.51MShares$21.1 Million1.08% of portfolio
-
Ubs Group Ag2.21MShares$18.6 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.13MShares$17.9 Million0.02% of portfolio
About Singular Genomics Systems, Inc.
- Ticker OMIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 71,193,296
- Market Cap $599M
- Description
- Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...